Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

GAITHERSBURG, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world​, today announced that Joe C. Papa, president and chief executive officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 1:30 PM PST.

The audio link for Emergent’s session may be accessed here and will be live for up to 30 days.

The company’s slides will be made available at the time of the presentation on the Investors section of the Emergent website.

About Emergent BioSolutions
At Emergent, our mission is to protect and enhance life. For over 25 years, we’ve been at work defending people from things we hope will never happen—so we are prepared just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we help protect public health, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify

Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com

Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com

Staff

Recent Posts

FitSpresso Review: Why Fitspresso Coffee Loophole Is Better Than Other Weight Loss Supplement in 2025?

FitSpresso is the perfect choice for those seeking an effective solution to achieve healthy weight…

3 hours ago

Amid California Wildfires, eNavvi Mobilizes Unlimited Prescription Credits for Healthcare Providers

LOS ANGELES, Jan. 9, 2025 /PRNewswire/ -- In response to the widespread fires currently devastating Los…

12 hours ago

SynCardia Systems Receives Decision to Grant First Patent in China for the Emperor Next-Generation Total Artificial Heart

TUCSON, Ariz., Jan. 9, 2025 /PRNewswire/ -- SynCardia Systems, LLC ("SynCardia", or the "Company"), a…

12 hours ago

Danaher Announces Investment Partnership in Innovaccer Inc.

Partnership seeks to improve patient outcomes and experience through novel digital and diagnostic solutions.Investment aligns…

12 hours ago

TriNetX’s Founding CEO Announces Plans to Step Down

After 11 Years, Gadi Lachman to Conclude Operating Role, Remain on TriNetX's Board CAMBRIDGE, Mass.,…

12 hours ago